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Laser acupuncture therapyAbstract Background: Use of laser makes efﬁcient acupuncture application without the use of
stainless steel needles. Irradiation with laser of acupuncture points can produce effects of diminish-
ing inﬂammation, relieving pain, enhancing metabolism, improving tissue regeneration and immu-
nity.
Objectives: To discuss its efﬁcacy as non-pharmacological intervention that may provide a valu-
able adjunctive or alternative treatment for chronic respiratory diseases.
Subjects and methods: Indications were 31 patients suffering from chronic respiratory illness
(asthma, COPD, bronchiectasis and ILD). They were subdivided into a control group that received
conservative treatment with medication and a study group that received a 10 day course of LLL in
addition to medication. All patients were subjected to full history taking, Plain Chest X-ray and
HRCT chest. Parameters assessed before and after 10 days: BMI, ﬂow/volume loop and treadmill
6MWT.
Main results: There was no statistically signiﬁcant difference in the mean value of age, BMI and
sex difference between both groups. Also there was no statistically signiﬁcant difference regarding
baseline spirometric data and 6 MWD between both groups. There was a statistically signiﬁcant
improvement in FVC, FEV1, FEF 25–75% and 6 MWD after 10 days of laser when compared with
baseline data within the study group, while within the control group there was a statistically
1066 A.R. Mohamed, M.M. Shabansigniﬁcant improvement in FVC, FEV1 and 6 MWD after 10 days of medical treatment when com-
pared with baseline data. By comparing both groups, there was more signiﬁcant improvement in
FEV1 and 6 MWD after 10 days of laser when compared to the control group.
Conclusion: A ten-day course of LLL may be a useful adjunct to standard medical care for
chronic respiratory diseases, though this requires corroboration with larger studies.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Acupuncture is an integral part of a 4000-year-old philosophy
of medicine that is known as traditional Chinese medicine
(TCM). Acupuncture is a therapy that involves the stimulation
of deﬁned points on the body with the use of needles for
therapeutic and preventive purposes. Other methods of stimu-
lation of acupuncture points include pressure (acupressure),
electric and more recently the use of laser [1].
The basic idea underlying acupuncture therapy is that
disorders related to the ﬂow of ‘Qi’, thought to be the energetic
life force moving through the body along a network of chan-
nels or pathways called meridians in the concept of TCM,
can be prevented or treated by stimulating the relevant points
on the body surface. By and large, these channels or pathways
are modulated in such a way as to stimulate, when there is a
deﬁciency or lack of energy, or reduce, when excess energy is
present [1].
Laser therapy has biostimulative and tissue regenerative
properties as well as antimicrobial, anti-inﬂammatory and
analgesic effects [2]. Studies on its effects in respiratory disease
have shown improvement in both gas exchange and pulmon-
ary function, as well as enhanced immunity and other health
beneﬁts [2].
There are several extraordinary effects that have been
observed with therapeutic lasers, and phototherapy makes
laser therapy unique among the various healing modalities
available today. Photobiomodulation produces changes in
oxidation/reduction status of the mitochondria which leads
to dramatic increases in ATP synthesis. Activation of the
sodium/potassium pump alters the cell membrane permeability
to calcium [3,4].
Phototherapy has been shown to effect cellular activity in
the following ways: stimulates cell growth, increases cell
metabolism, improves cell regeneration, invokes an anti-
inﬂammatory response, promotes edema reduction, reduces
ﬁbrous tissue formation, stimulates nerve function, reduces
the production of substance P, stimulates long term produc-
tion of nitric oxide, decreases the formation of bradykinin, his-
tamine, and acetylcholine and stimulates the production of
endorphins [4].
One of the basic properties of low level laser (LLL) seems to
be the ability to inhibit inﬂammation at the level of innate
immune activation. Representative studies showed that LLL
was capable of suppressing inﬂammatory genes and/or pathol-
ogy after the administration of lipopolysaccharide (LPS) as a
stimulator of monocytes and bronchial cells, in vitro, and leu-
kocyte inﬁltration in vivo. Inﬂammation induced by other
stimulators such as zymosan, carrageenan, and TNF-alpha
was also inhibited by LLL. Growth factor stimulating activity
of LLL was demonstrated in both in vitro and in vivoexperiments in which augmentation of FGF-2, PDGF and
IGF-1 was observed. Endogenous production of these growth
factors may be useful in regeneration based on activation of
endogenous pulmonary stem cells [5].
Bronchial asthma is a major health problem characterized
by a chronic inﬂammatory disorder of the airways, in which
many cells and cellular elements play a role [1]. COPD is a
major global health problem predicted to rank as the third
greatest cause of mortality by the end of the next decade, it
is a slowly progressive and poorly reversible inﬂammatory
disease characterized by the functional abnormality of airway
obstruction, which includes emphysema, chronic bronchitis,
and small airways disease [6]. Inhibition of the inﬂammatory
response may represent an important therapeutic strategy for
COPD [6].
As a consequence, therapeutic intervention in chronic respi-
ratory diseases would require addressing the issues of inﬂam-
mation and regeneration. The present study aimed to develop
a possible rationale for how LLL may be useful as a non-phar-
macological intervention that may provide a valuable adjunc-
tive or alternative treatment for chronic respiratory diseases.
Subjects and materials
Thirty-one patients suffer from chronic respiratory illness, of
both sexes (12 females and 19 males), their age ranged between
19 and 70 years. All subjects were recruited from the outpa-
tient chest clinic of the Kasr Alainy hospital. Patients with
other chronic diseases that may contribute to exercise limita-
tion; such as: cardiac, renal and liver diseases were excluded.
Malignancies and those with Lack of motivation and Non-
adherence were also excluded. No symptoms of respiratory
infection were seen for 4 weeks before the study.
They were sub-divided into the control group (n= 15) and
the study group (n= 16) The control group included patients
that received conservative treatment with medication only
while the study group included patients that received a ten-
day course of low level laser therapy, in addition to conserva-
tive treatment with medication.
All patients were subjected to: Full history taking including
medical history and clinical examination, Plain Chest X-ray
(P-A view) and HRCT chest.
In the study group, patients were subjected to low level
laser therapy using (Phyaction CL) with output of 5–20 mW,
wavelength of 905 nm and frequency of 5000 Hz. laser probe
placed in intercostal space corresponding to the site of lesion
both anteriorly and posteriorly on chest wall and arm as: Stan-
dardized laser acupuncture application with 7 points (LU-1,
LU-2, CU-17, BL-13, BL-17, LU-5, LU-7). Each acupuncture
point was stimulated for 1 min with total number of applica-
tions: daily for 10 days [7].
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BMI or Quetelet index: it is deﬁned as the individual’s body
mass divided by the square of their height – with the value uni-
versally being given in units of kg/m2 [8].
Pulmonary function test: (ﬂow/volume loop): using body
plethysmography with highly transparent box; Sensor-medics
V max series, 2130 Spirometer, V6200 Autobox, 6200DL. Spi-
rometry indices are reported comparing the individual’s value
along with the predicted values [9]. The forced vital capacity
(FVC), the forced expiratory volume in the ﬁrst second
(FEV1), the ratio of FEV1 to FVC and the average of forced
expiratory ﬂow at 25–75% of forced vital capacity (FEF 25–
75%) were measured. When asthma is strongly suspected the
response to bronchodilator aerosol is measured (Bronchodila-
tor challenge test), reversible airway obstruction characterized
by an increase in FEV1 that is both greater than 200 ml (abso-
lute change) and 12% (% change) above the pre-bronchodila-
tor FEV1 is characteristic of asthma [10].
Treadmill six-min walk test: using Electrical treadmill
(Schiller Quinton 4000). Use of a treadmill to determine the
6 MWD allows constant monitoring during the exercise. Stan-
dardized instructions and encouragement similar to those for
the corridor walk were given, according to ATS guidelines
[11]. Patients were instructed to walk ‘‘as far as possible’’ dur-
ing the time-that is, as fast as possible. They were told that
they could slow down or even stop if necessary. There was
no warming up before test. The initial treadmill speed was
zero, and the test began when the treadmill was activated
and the patient started walking. The patient controlled the
treadmill speed during the test and could stop to rest at any
time, as in the hallway test. Before, during, or after treadmill
walk test, the walk testing was discontinued if the patient
had thoracic pain, intolerable dyspnea, cramps, dizziness,
staggering, diaphoresis, and pallor [11].
Statistical analysis
Data were statistically described in terms of mean ± standard
deviation (±SD), median and range. Comparison between the
study groups was done using Student’s t-test for independent
samples. Within group comparison was done using paired t-
test. P values less than 0.05 were considered statistically signif-
icant. All statistical calculations were done using computer
program SPSS (Statistical Package for the Social Science;
SPSS Inc., Chicago, IL, USA) version 15 for Microsoft
Windows.
Results
The present study included 31patients, they were selected from
the outpatient chest clinic, Kasr Alainy hospital. They were
further sub-divided into the control group (n= 15) and the
study group (n= 16). The control group included patients that
received conservative treatment with medication only while the
study group included patients that received a ten-day course of
LLL, in addition to conservative treatment with medication.
The indications of those who suffer from chronic
respiratory illness are as shown in (Fig. 1).
In the present study, there was no statistically signiﬁcant
difference between the control group and the study group inthe mean value of age and BMI with P-values 0.75 and 0.55,
respectively as shown (Fig. 2), also there was no statistically
signiﬁcant difference in sex between the two groups with P-
value 0.88 as shown in (Fig. 3).
Regarding Baseline spirometric data and 6 MWD of both
groups, it was shown that there was no statistically signiﬁcant
difference between the control and study group as shown in
(Table 1).
There was a statistical signiﬁcant improvement in
mean ± SD of FVC, FEV1, FEF 25–75% and 6 MWD after
10 days of laser therapy when compared with baseline data
within the study group as shown (Table 2), while within the
control group there was a statistical signiﬁcant improvement
Table 1 Baseline spirometric data and 6 MWD for the participants.
Baseline data Control group
(n= 15)
Study group
(n= 16)
Total participants
(n= 31)
P-Value Statistical signiﬁcance
FVC% (mean ± SD) 58.13 ± 19.00 59.69 ± 14.29 58.94 ± 16.47 0.79 Not signiﬁcant
FEV1% (mean ± SD) 43.00 ± 19.86 49.50 ± 15.74 46.35 ± 17.86 0.32 Not signiﬁcant
FEV1/FVC% (mean ± SD) 59.40 ± 18.38 68.24 ± 15.23 63.96 ± 17.14 0.155 Not signiﬁcant
FEF 25–75% (mean ± SD) 26.47 ± 24.38 33.56 ± 22.45 30.13 ± 23.29 0.406 Not signiﬁcant
6 MWD (in meters) (mean ± SD) 32.67 ± 10.33 30.94 ± 11.52 31.77 ± 10.81 0.66 Not signiﬁcant
P-Value < 0.05 statistically signiﬁcant.
Table 3 BMI, spirometric data and 6 MWD for the control group baseline and after 10 days of medical treatment.
Data after 10 days of medical treatment Control group (n= 15) P-Value Statistical signiﬁcance
Baseline After 10 days
BMI kg/m2 (mean ± SD) 27.80 ± 6.12 27.67 ± 5.97 0.334 Not signiﬁcant
FVC% (mean ± SD) 58.13 ± 19.00 54.13 ± 18.79 0.033 Signiﬁcant
FEV1% (mean ± SD) 43.00 ± 19.86 39.60 ± 19.29 0.013 Signiﬁcant
FEV1/FVC% (mean ± SD) 59.40 ± 18.38 59.93 ± 16.01 0.833 Not signiﬁcant
FEF 25–75% (mean ± SD) 26.47 ± 24.38 26.07 ± 24.95 0.754 Not signiﬁcant
6 MWD in meters (mean ± SD) 32.67 ± 10.33 39.67 ± 13.29 0.001 Signiﬁcant
P-Value < 0.05 statistically signiﬁcant.
Table 2 BMI, spirometric data and 6 MWD for the study group baseline and after 10 days of laser therapy.
Data after 10 days of laser therapy Study group (n= 16) P-Value Statistical signiﬁcance
Baseline After 10 days
BMI kg/m2 (mean ± SD) 26.52 ± 5.60 26.82 ± 5.68 0.089 Not signiﬁcant
FVC% (mean ± SD) 59.69 ± 14.29 65.44 ± 18.38 0.015 Signiﬁcant
FEV1% (mean ± SD) 49.50 ± 15.74 55.25 ± 16.11 0.009 Signiﬁcant
FEV1/FVC% (mean ± SD) 68.24 ± 15.23 70.69 ± 15.29 0.180 Not signiﬁcant
FEF 25–75% (mean ± SD) 33.56 ± 22.45 38.88 ± 22.45 0.003 Signiﬁcant
6 MWD in meters (mean ± SD) 30.94 ± 11.52 93.63 ± 29.96 0.000 Signiﬁcant
P-Value < 0.05 statistically signiﬁcant.
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medical treatment when compared with its baseline data as
shown in (Table 3).
By comparing both groups after 10 days of treatment, there
was more signiﬁcant improvement in mean ± SD of FEV1and
6 MWD after 10 days of laser therapy when compared to the
control group as shown in (Table 4).Discussion
Laser therapy in general, is safe and can be often used where
other physical modalities are contraindicated such as with
pace-makers or metal implants [4]. Laser phototherapy can
be of value in the mitigation and elimination of many painful
conditions [4,12].
Laser phototherapy is easily applied to patients and has rel-
atively short treatment times, depending on the power output
of the device, the wavelengths used and the size of the area to
be treated. There are no known permanent or serious side
effects from laser therapy. [4,13].
The medical use of LLL irradiation has been occurring for
decades, primarily in the area of tissue healing and inﬂammatoryconditions. Despite little mechanistic knowledge, the concept of
a non-invasive, non-thermal intervention of laser acupuncture,
the present study aimed to discuss its efﬁcacy as a non-pharma-
cological intervention that may provide a valuable adjunctive or
alternative treatment for chronic respiratory diseases.
While the present study tried to ﬁnd out the efﬁcacy of LLL
on measured pulmonary function parameters and 6 MWD for
asthma, COPD, bronchiectasis and ILD, other studies showed
its efﬁcacy in other chest diseases.
Amirov [14] divided 142 patients with pneumonia into two
groups. The study group (96 patients) received laser therapy in
combination with pharmaceuticals, while the control group (46
patients) was treated solely with drugs. A pronounced reduc-
tion in cell membrane permeability, a rise in concentrations
of iron and chromium in the blood serum, and improvement
of microcirculation were observed in those receiving laser
treatment. Amirov [14] found, ‘‘These changes closely
correlated with those in immunity, external respiration func-
tion and Concluded that Laser therapy is an effective method
of pneumonia treatment and can be included in relevant
combined schemes.’’
In another study, Lutai et al. [15] compared two groups of
patients with pneumonia. The study group received laser
Table 4 BMI, spirometric data and 6 MWD for the participants after 10 days of treatment.
Data after 10 days of treatment Control group
(n= 15)
Study group
(n= 16)
Total participants
(n= 31)
P-Value Statistical signiﬁcance
BMI kg/m2 (mean ± SD) 27.67 ± 5.97 26.82 ± 5.68 27.23 ± 5.74 0.688 Not signiﬁcant
FVC% (mean ± SD) 54.13 ± 18.79 65.44 ± 18.38 59.97 ± 19.15 0.101 Not signiﬁcant
FEV1% (mean ± SD) 39.60 ± 19.29 55.25 ± 16.11 47.68 ± 19.14 0.020 Signiﬁcant
FEV1/FVC% (mean ± SD) 59.93 ± 16.01 70.69 ± 15.29 65.49 ± 16.23 0.066 Not signiﬁcant
FEF 25–75% (mean ± SD) 26.07 ± 24.95 38.88 ± 22.45 32.68 ± 24.18 0.143 Not signiﬁcant
6 MWD in meters (mean ± SD) 39.67 ± 13.29 93.63 ± 29.96 67.52 ± 34.60 0.000 Signiﬁcant
P-Value < 0.05 statistically signiﬁcant.
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There was an earlier regression of clinical symptoms and a
more rapid recovery of lung function in the group treated with
laser therapy. The authors [15] concluded that, ‘‘non-drug
treatment had an undeniably positive impact. In the absence
of side effects of this method, infrared laser therapy can be
recommended for rehabilitation of elderly patients with
pneumonia.’’
Hacerova and Hubacek [16] studied the effect of laser acu-
puncture on acute sinusitis when compared to the control
group on medical treatment. They found that laser irradiation
causes a quicker withdrawal of inﬂammation and edema of the
mucosa and thus brings restoration of drainage of sinus as well
as normalization of mucociliary function and this strategy may
be a great starting point for the treatment of other respiratory
conditions.
Puri and Arora [17] studied the bio-stimulatory effects of
Gallium Arsenide Laser Irradiation at 890 nm as an adjunctive
to anti-tuberculosis drugs in the treatment of pulmonary
tuberculosis, one hundred thirty new sputum smear positive
patients of pulmonary tuberculosis were included, they were
randomly divided into two groups to receive either LLL or
sham irradiation (control) concomitantly with anti-tuberculo-
sis, Puri and Arora [17] concluded that there was a faster clear-
ance of tubercle bacilli in the sputum of patients who were
treated with LLL along with anti-tuberculosis treatment when
compared to the control group and this improves the bacteri-
ological cure and prevents secondary resistance. These ﬁndings
provide evidence that LLL with Gallium Arsenide Irradiation
may have bio-stimulatory effect as an adjuvant therapy for
patients with tuberculosis.
The present study showed that there was a more signiﬁcant
improvement in mean ± SD of FEV1 and 6 MWD after
10 days of laser therapy when compared to the control group.
Although acupuncture treatment is commonly used in rou-
tine practice by qualiﬁed practitioners of traditional TCM in a
variety of clinical settings and despite thousands of years of
use, there is no robust evidence base to conﬁrm its effectiveness
in the treatment of asthma [18,19].
Evidence suggests that there is inconclusive evidence to
indicate that short term (1–12 weeks) acupuncture treatment
has a signiﬁcant effect on the course of asthma when used in
conjunction with drug maintenance treatment [7].
In contrast, Milojevic and Kuruc [20] treated 50 patients
with bronchial asthma using laser acupuncture for 10 days,
comparing changes with those of a control group of the same
number of patients, differing only in that laser acupuncture
was not given. Milojevic and Kuruc [20] found that ‘‘A ten-
day course of low-power laser stimulation of acupuncturepoints in patients with bronchial asthma improves both the
lung function and gas exchange parameters. Positive effects
of laser treatment in patients with bronchial asthma are
achieved in a short time and they last long, for several weeks,
even months. Successive laser stimulation in asthmatics
prolongs periods of remission and decreases the severity of
asthmatic attacks.
Similarly Ailioaie and Ailioaie [21] compared the effects of
laser acupuncture and pharmaceutical drugs in asthma. The
authors reported, ‘‘A noticeable improvement in the clinical,
functional and immunological characteristics was observed in
83% of the patients in group with laser acupuncture
treatment’’.
Suzuki et al. [22] tried to determine whether a combination
of traditional acupuncture treatment and conservative treat-
ment for COPD improves dyspnea on exercise. The study
included the acupuncture group (n= 15) that received acu-
puncture treatments once a week for 10 weeks and the control
group (n= 15) that received conservative treatment with med-
ication only. The authors [22] found that the acupuncture
group had signiﬁcantly better results on the Borg scale than
the control group after 10 weeks. Also the 6-min walk distance
and oxygen saturation improved signiﬁcantly in the acupunc-
ture group compared with the control group.
In contrast, Bausewein et al. [23] looked at the effectiveness
of non-pharmacological and non-invasive interventions to
relieve breathlessness in participants suffering from the ﬁve
most common conditions causing breathlessness in advanced
disease. It included 47 randomized controlled and controlled
clinical trials involving a total of 2532 participants described
as suffering from breathlessness due to advanced stages of can-
cer, COPD, interstitial lung disease, chronic heart failure or
motor neuron disease. Five of the trials were of acupuncture/
acupressure, which provided low strength evidence that
acupuncture/acupressure is helpful. Most of the studies had
been conducted in patients with COPD.Conclusion
A ten-day course of low-power laser stimulation may be a
useful adjunct to standard medical care for chronic respiratory
diseases. Despite the availability, cost-effective efﬁcacy and
safety of LLL, the ﬁeld is still in its infancy. As is obvious from
the wide variety of LLL sources, frequencies, intensities used
and no standard protocols exist. Further research is required
to investigate the mechanism of the apparent effectiveness of
laser acupuncture, which patients may be helped and which
protocols are most effective.
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